Studies that involve the use of Recombinant DNA or potentially Pathogenic agents in human subjects must be reviewed and approved by the Institutional Biosafety Committee (IBC).
Investigators who intend to submit a human pathogen or gene transfer protocol to the Johns Hopkins Institutional Review Board (IRB) should contact the Biosafety Officer for IBC submission details.


